CN103893558A - Traditional Chinese medicine for treating leucoderma - Google Patents
Traditional Chinese medicine for treating leucoderma Download PDFInfo
- Publication number
- CN103893558A CN103893558A CN201410094471.3A CN201410094471A CN103893558A CN 103893558 A CN103893558 A CN 103893558A CN 201410094471 A CN201410094471 A CN 201410094471A CN 103893558 A CN103893558 A CN 103893558A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- caulis spatholobi
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating leucoderma, which is prepared from the following raw medicinal materials in parts by weight: 1-2 parts of schizonepeta, 1-2 parts of tribulus terrestris, 2-3 parts of caulis spatholobi, 1-2 parts of pillis ophidiae, 1-2 parts of jasminum subtriplinerve, 2-3 parts of rice-shell, 1-3 parts of viola arcuata, 2-4 parts of meadowrue root and rhizome, 2-4 parts of pulp of dogwood fruit, 1-5 parts of cockscomb, 1-4 parts of cortex acanthopanacis, 1-2 parts of lumbricus, 1-2 parts of umbilicaria esculenta, 2-4 parts of ground beeltle, 3-5 parts of radix clematidis, 8-10 parts of cortex dictamni, 14-16 parts of lithospermum, 4-6 parts of fructus psoraleae, 9-12 parts of smoked plum, 9-12 parts of caulis spatholobi, 9-12 parts of carcuma longa, 10-12 parts of sanguis draconis, 2-3 parts of muskone, and 9-12 parts of edible tulip.
Description
Technical field
The present invention relates to treat the field of Chinese medicines, is exactly that one is treated leukodermic Chinese medicine.
Background technology
Vitiligo is a kind of common posteriority limit office property or general the de-disease of losing of property skin pigment.Cause because the melanocyte function of skin disappears, but mechanism is not clear.The each position of whole body can occur, and is common in and refers to that the back of the body, wrist, forearm, face, neck and genitals are etc. around.Female genitalia also can occur, and young women is in the majority.
Summary of the invention
The object of this invention is to provide one and treat leukodermic Chinese medicine.
The present invention adopts following technical scheme:
One is treated leukodermic Chinese medicine, it is characterized in that, it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1-2, Fructus Atriplicis Sibiricae 1-2, Caulis Spatholobi 2-3, Periostracum Serpentis 1-2, Jasminum nervosum Lour 1-2, olive 2-3, Viola arcuata 1-3, Radix et Rhizoma Thalictri 2-4, Fructus Corni 2-4, Flos Celosiae Cristatae 1-5, Cortex Acanthopancis 1-4, Pheretima 1-2, Umbillcaria esculenta 1-2, Eupolyphaga Seu Steleophaga 2-4, Radix Clematidis 3-5, Cortex Dictamni 8-10, Radix Arnebiae (Radix Lithospermi) 14-16, Fructus Psoraleae 4-6, Fructus Mume 9-12, Caulis Spatholobi 9-12, Rhizoma Curcumae Longae 9-12, the brown 10-12 of blood, artificial Moschus 2-3, Pseudobulbus Cremastrae Seu Pleiones 9-12.
The leukodermic Chinese medicine of described treatment, it is characterized in that: it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
Beneficial effect of the present invention is:
The present invention's removing toxic substances, hyperchromic, cures mainly: vitiligo, white macula.
The specific embodiment
The leukodermic Chinese medicine of described treatment, it is to be made up of the crude drug of following weight (g): Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
Method for making usage: after above-mentioned all crude drug are mixed, with after 1.5 liters of soaking in Chinese liquor 6-8 days, get liquid and be coated with outward, once a day.
Function cures mainly: removing toxic substances, hyperchromic, cures mainly: vitiligo, white macula.
model case
Case 1: patient is permitted so-and-so, female, 18 years old, more than upper limb and cervical region occur that many places differ in size white macula half a year, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after three months, follow up a case by regular visits to not recurrence in a year;
Case 2: patient Zhu, female, 52 years old, there is the white macula differing in size in back, buttocks both sides, and symmetrical, more than a year, gives the present embodiment medicine affected part of exterior coating treatment recovery from illness after five months, follows up a case by regular visits to not recurrence in a year;
Case 3, patient Liu so-and-so, female, 31 years old, in cervical region place and right side chest breast all have the white macula differing in size of dispersion, more than 2 years, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after eight months, follow up a case by regular visits to not recurrence in a year;
Case 4, patient cattle so-and-so, man, 22 years old
There is the white macula differing in size in the both sides corners of the mouth, more than January, gives the present embodiment medicine affected part of exterior coating treatment recovery from illness after four months, follows up a case by regular visits to not recurrence in a year;
Case 5, patient Zhang, man, 17 years old
In the two cheekbones lamellar white macula that around differs in size, more than 3 years, give the present embodiment medicine affected part of exterior coating treatment recovery from illness after ten months, follow up a case by regular visits to not recurrence in a year.
Claims (2)
1. the leukodermic Chinese medicine for the treatment of, it is characterized in that, it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1-2, Fructus Atriplicis Sibiricae 1-2, Caulis Spatholobi 2-3, Periostracum Serpentis 1-2, Jasminum nervosum Lour 1-2, olive 2-3, Viola arcuata 1-3, Radix et Rhizoma Thalictri 2-4, Fructus Corni 2-4, Flos Celosiae Cristatae 1-5, Cortex Acanthopancis 1-4, Pheretima 1-2, Umbillcaria esculenta 1-2, Eupolyphaga Seu Steleophaga 2-4, Radix Clematidis 3-5, Cortex Dictamni 8-10, Radix Arnebiae (Radix Lithospermi) 14-16, Fructus Psoraleae 4-6, Fructus Mume 9-12, Caulis Spatholobi 9-12, Rhizoma Curcumae Longae 9-12, the brown 10-12 of blood, artificial Moschus 2-3, Pseudobulbus Cremastrae Seu Pleiones 9-12.
2. the leukodermic Chinese medicine for the treatment of according to claim 1, it is characterized in that: it is to be made up of the crude drug of following weight portion: Herba Schizonepetae 1, Fructus Atriplicis Sibiricae 2, Caulis Spatholobi 3, Periostracum Serpentis 1, Jasminum nervosum Lour 1, olive 3, Viola arcuata 1, Radix et Rhizoma Thalictri 4, Fructus Corni 2, Flos Celosiae Cristatae 1, Cortex Acanthopancis 1, Pheretima 2, Umbillcaria esculenta 2, Eupolyphaga Seu Steleophaga 2, Radix Clematidis 5, Cortex Dictamni 10, Radix Arnebiae (Radix Lithospermi) 16, Fructus Psoraleae 6, Fructus Mume 9, Caulis Spatholobi 12, Rhizoma Curcumae Longae 9, blood are brown 10, artificial Moschus 3, Pseudobulbus Cremastrae Seu Pleiones 12.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410094471.3A CN103893558A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine for treating leucoderma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410094471.3A CN103893558A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine for treating leucoderma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103893558A true CN103893558A (en) | 2014-07-02 |
Family
ID=50985342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410094471.3A Pending CN103893558A (en) | 2014-03-14 | 2014-03-14 | Traditional Chinese medicine for treating leucoderma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103893558A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038861A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Chinese herbal medicine formula for treating leukoderma |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101406641A (en) * | 2008-11-24 | 2009-04-15 | 黄玉英 | Compound medicament for treating vitiligo |
CN101757139A (en) * | 2009-10-23 | 2010-06-30 | 成钢 | Traditional Chinese medicine with magnetic nano elements of selenium, copper, and zinc for externally treating leucoderma |
CN102038904A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Chinese prescription for treating leucoderma |
CN102430097A (en) * | 2011-11-29 | 2012-05-02 | 渠淑敏 | Chinese medicine for treating vitiligo |
CN103251847A (en) * | 2013-06-05 | 2013-08-21 | 高忠青 | Traditional Chinese medicine for treating leucoderma |
-
2014
- 2014-03-14 CN CN201410094471.3A patent/CN103893558A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101406641A (en) * | 2008-11-24 | 2009-04-15 | 黄玉英 | Compound medicament for treating vitiligo |
CN102038904A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Chinese prescription for treating leucoderma |
CN101757139A (en) * | 2009-10-23 | 2010-06-30 | 成钢 | Traditional Chinese medicine with magnetic nano elements of selenium, copper, and zinc for externally treating leucoderma |
CN102430097A (en) * | 2011-11-29 | 2012-05-02 | 渠淑敏 | Chinese medicine for treating vitiligo |
CN103251847A (en) * | 2013-06-05 | 2013-08-21 | 高忠青 | Traditional Chinese medicine for treating leucoderma |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038861A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Chinese herbal medicine formula for treating leukoderma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989818A (en) | Medicinal liquor | |
CN103861046A (en) | Traditional Chinese medicine for treating prosopalgia | |
CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
CN103028055B (en) | Traditional Chinese medicine for treating migraine | |
CN103893558A (en) | Traditional Chinese medicine for treating leucoderma | |
CN104815038B (en) | A kind of external-applied ointment for acupuncture therapy | |
CN103341126B (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
CN102793904A (en) | Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture | |
CN105106837A (en) | Traditional Chinese medicine combination for treating viral hepatitis | |
CN104288440A (en) | Traditional Chinese medicine ointment for treating vitiligo | |
CN102961454A (en) | Method for treating scapulohumeral periarthritis and preparation method for same | |
CN103191230A (en) | Traditional Chinese medicine for treating infantile recurrent hordeolum | |
CN104510861A (en) | Traditional Chinese medicine for treating rheumatoid disease | |
CN104825924A (en) | Traditional Chinese medicine capable of promoting digestion and relieving stasis | |
CN105106706A (en) | Externally-used liniment for treating allergic dermatitis | |
CN105233103A (en) | Traditional Chinese medicine decoction for treating urinary tract infection | |
CN104922443A (en) | External-use patch for treating rheumatic arthritis | |
CN104888039A (en) | Traditional Chinese medicine capable of promoting digestion and relieving stasis | |
CN104474270A (en) | Traditional Chinese medicine composition and application thereof | |
CN104001031A (en) | Medicament for treating asthma | |
CN103285289A (en) | Traditional Chinese medicine for treating arthralgia | |
CN103041218A (en) | Traditional Chinese medicine composition for treating common cold | |
CN103933336A (en) | Traditional Chinese medicine combination for treating leucoderma | |
CN104083645A (en) | A traditional Chinese medicine composition treating postpartum body weakness dizziness | |
CN103239536A (en) | Traditional Chinese medicine for treating influenza and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140702 |